BETA-MIMETIC DRUGS AND POSSIBLE PREVENTION OF RESPIRATORY DISTRESS SYNDROME

  1. G. Boog Assistant,
  2. M. Ben Brahim Resident Assistant,
  3. R. Gandar Professor

Article first published online: 23 AUG 2005

DOI: 10.1111/j.1471-0528.1975.tb00635.x

Issue

BJOG: An International Journal of Obstetrics & Gynaecology

BJOG: An International Journal of Obstetrics & Gynaecology

Volume 82, Issue 4, pages 285–288, April 1975

Additional Information

How to Cite

Boog, G., Ben Brahim, M. and Gandar, R. (1975), BETA-MIMETIC DRUGS AND POSSIBLE PREVENTION OF RESPIRATORY DISTRESS SYNDROME. BJOG: An International Journal of Obstetrics & Gynaecology, 82: 285–288. doi: 10.1111/j.1471-0528.1975.tb00635.x

Author Information

  1. Department of Obstetrics and Gynaecology I University of Strasbourg, France

Publication History

  1. Issue published online: 23 AUG 2005
  2. Article first published online: 23 AUG 2005

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (269K)

Summary

The prophylactic value of beta-mimetic drugs in preventing respiratory distress syndrome (RDS) is investigated by comparing 29 preterm infants of ritodrine treated mothers with 34 preterm infants of a control group. Five cases of RDS (17 per cent) occurred among the infants of treated mothers as compared with 12 cases (35 per cent) in the control group (p=0.09). The difference is, however, statistically significant for the group of infants weighing less than 2300 grams (p=0.01) which includes all infants affected with RDS.

Get PDF (269K)